Focal Medical (Drug Delivery) Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
Focal Medical (Drug Delivery) General Information
Description
Developer of energy-based localized drug delivery systems designed for targeted treatment of solid tumors. The company's platform uses a controlled electric field to transport small-molecule drugs directly into tumor cells, increasing local drug concentration while minimizing systemic exposure, and supports clinical development, enabling oncologists to treat refractory cancers with reduced side effects.
Contact Information
Website
www.focalmedical.co(Operating Subsidiary)
Corporate Office
- 111 James Jackson Avenue
- Suite 131
- Cary, NC 27513
- United States
Corporate Office
- 111 James Jackson Avenue
- Suite 131
- Cary, NC 27513
- United States
Focal Medical (Drug Delivery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 04-Jun-2025 | Completed | Clinical Trials - Phase 1 | |||
| 10. Later Stage VC (Series A2) | Cancelled | Clinical Trials - Phase 1 | ||||
| 9. Later Stage VC | 01-Mar-2024 | Completed | Clinical Trials - Phase 1 | |||
| 8. Later Stage VC (Series A) | 25-Feb-2022 | Completed | Clinical Trials - Phase 1 | |||
| 7. Grant | 12-Aug-2021 | Completed | Clinical Trials - Phase 1 | |||
| 6. Grant | 17-Sep-2018 | Completed | Clinical Trials - Phase 1 | |||
| 5. Debt - General | 01-Jan-2018 | Completed | Clinical Trials - Phase 1 | |||
| 4. Seed Round | 04-Dec-2017 | Completed | Product Development | |||
| 3. Grant | 21-Sep-2017 | $300K | Completed | Product Development | ||
| 2. Grant | 01-Sep-2017 | $500K | Completed | Product Development |
Focal Medical (Drug Delivery) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed 1 | ||||||||
| Seed | 380,000 | $0.001000 | 8% | $0.72 | $0.72 | 1x | $0.72 | 14.7% |
Focal Medical (Drug Delivery) Comparisons
Industry
Financing
Details
Focal Medical (Drug Delivery) Competitors (19)
One of Focal Medical (Drug Delivery)’s 19 competitors is TriSalus Life Sciences, a Formerly VC-backed company based in Westminster, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TriSalus Life Sciences | Formerly VC-backed | Westminster, CO | ||||
| RenovoRx | Formerly VC-backed | Mountain View, CA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| Rakuten Medical | Venture Capital-Backed | San Diego, CA |
Focal Medical (Drug Delivery) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Focal Medical (Drug Delivery) Patents
Focal Medical (Drug Delivery) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025179247-A1 | Delivery of chemotherapy drug via an implantable iontophoresis drug delivery device | Pending | 23-Feb-2024 | ||
| ES-2978222-T3 | Implantable reservoir for use with a medical device and a system for interventional drug delivery | Active | 26-Nov-2018 | ||
| CA-3121123-A1 | Implantable reservoir for use with a medical device and system for interventional drug delivery | Pending | 26-Nov-2018 | ||
| EP-3886975-A1 | Implantable reservoir for use with a medical device and system for interventional drug delivery | Active | 26-Nov-2018 | ||
| EP-3886975-B1 | Implantable reservoir for use with a medical device and system for interventional drug delivery | Active | 26-Nov-2018 | A61N1/306 |
Focal Medical (Drug Delivery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Focal Medical (Drug Delivery) Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| First Flight Venture Center | Accelerator/Incubator | |||
| Khosla Ventures | Venture Capital | Minority | ||
| National Cancer Institute | Government | |||
| North Carolina Biotechnology Center | Not-For-Profit Venture Capital | Minority | ||
| Piedmont Capital Partners | Real Estate | Minority |
Focal Medical (Drug Delivery) FAQs
-
When was Focal Medical (Drug Delivery) founded?
Focal Medical (Drug Delivery) was founded in 2014.
-
Where is Focal Medical (Drug Delivery) headquartered?
Focal Medical (Drug Delivery) is headquartered in Cary, NC.
-
What is the size of Focal Medical (Drug Delivery)?
Focal Medical (Drug Delivery) has 12 total employees.
-
What industry is Focal Medical (Drug Delivery) in?
Focal Medical (Drug Delivery)’s primary industry is Drug Delivery.
-
Is Focal Medical (Drug Delivery) a private or public company?
Focal Medical (Drug Delivery) is a Private company.
-
What is Focal Medical (Drug Delivery)’s current revenue?
The current revenue for Focal Medical (Drug Delivery) is .
-
How much funding has Focal Medical (Drug Delivery) raised over time?
Focal Medical (Drug Delivery) has raised $15.3M.
-
Who are Focal Medical (Drug Delivery)’s investors?
First Flight Venture Center, Khosla Ventures, National Cancer Institute, North Carolina Biotechnology Center, and Piedmont Capital Partners are 5 of 6 investors who have invested in Focal Medical (Drug Delivery).
-
Who are Focal Medical (Drug Delivery)’s competitors?
TriSalus Life Sciences, RenovoRx, Xenetic Biosciences, Renova Therapeutics, and Rakuten Medical are some of the 19 competitors of Focal Medical (Drug Delivery).
-
When was Focal Medical (Drug Delivery) acquired?
Focal Medical (Drug Delivery) was acquired on 04-Jun-2025.
-
Who acquired Focal Medical (Drug Delivery)?
Focal Medical (Drug Delivery) was acquired by Continuity Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
